Delivered-To: tjphuhs@gmail.com Received: by 2002:a5d:51c9:0:b0:451:8158:aa77 with SMTP id n9csp745074wrv; Wed, 13 May 2026 18:05:58 -0700 (PDT) X-Received: by 2002:a05:600c:c091:b0:48e:74dc:999f with SMTP id 5b1f17b1804b1-48fce9b5c0cmr53444465e9.6.1778720757979; Wed, 13 May 2026 18:05:57 -0700 (PDT) ARC-Seal: i=1; a=rsa-sha256; t=1778720757; cv=none; d=google.com; s=arc-20240605; b=bbNCmJ5kUyM6eRgMaO6KSYx+snUdgXMSV3QRXKVM12QHm0ADEhLoleMIW9pNSbn9UU hMHghfDFPxvJp5LxNBr8yckUlTCIGvFBKijsNCunO9OHz37iQ584TNtHX/kWUx2nN2Yn ccpZAaoXvoWTQx2rxrUer/HstiRF7vQlxcS662fJjz+ou6Xy5ldLZjYznQdHHoUyxoU4 dqF5Var6ueM5SA4IfXPjP/m4KOup8C+iSM+18R8KTzjCr058ZmKIffGL7pLGU7dDzIf4 y5Qjf8+NLPTZOwrnP0yzyT6ngT+n4hzWReEMDpy6kdQcbRRJTyGJHcKfXm0vGBm0fN2o 77+g== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=reply-to:message-id:mime-version:list-unsubscribe-post :list-unsubscribe:list-id:from:feedback-id:date:subject:to :dkim-signature:dkim-signature; bh=PoOQLY37ogW+D6I/xDjdxwlikPDxaBObL3v/xelGIQk=; fh=aUbTe0PB4rBmjvxO+ACBuKX8nUsE2vLi02KV92FPMDs=; b=L3CA2dV8LRyrNT+YiE2E/OSZeVM8KmIRoLyT0Tqa6ZI9id10ODIbXS2AurcuY9GBrq 6TITVwAFLcME5zssTRK44GbQ+oRs/VIWZ65LPWVnPFqqhS8Nt7RNS40eAd0gVSiOcrvB F/i34WJ/svfZiImkVXkPP9yLQVavE7OZX1lYLQgzkdorig66tMwEGh9HDl/gFSHzaNkC VEjkjpwm/zT5UNk+RH4N11Vyg9gSRk7OkkkaNE6/73WK+OikZrNB9/Mz1j8NLs8gV5In xfg7saRq6JP4u8ms4FhiT1B1a1pXuF4ywi49NXWmZnT3RAAFPdhanHs3rTzei9rNK0/N f2cw==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@happypeps.co header.s=brevo2 header.b=Que7xnW0; dkim=pass header.i=@mailin.fr header.s=mail header.b=umrYJm3E; spf=pass (google.com: domain of bounces-m10df-info=happypeps.co@ht.d.sender-sib.com designates 77.32.148.46 as permitted sender) smtp.mailfrom="bounces-m10df-info=happypeps.co@ht.d.sender-sib.com"; dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=happypeps.co Return-Path: Received: from ht.d.sender-sib.com (ht.d.sender-sib.com. [77.32.148.46]) by mx.google.com with ESMTPS id ffacd0b85a97d-45da1b6fb35si1864699f8f.223.2026.05.13.18.05.57 for (version=TLS1_3 cipher=TLS_AES_256_GCM_SHA384 bits=256/256); Wed, 13 May 2026 18:05:57 -0700 (PDT) Received-SPF: pass (google.com: domain of bounces-m10df-info=happypeps.co@ht.d.sender-sib.com designates 77.32.148.46 as permitted sender) client-ip=77.32.148.46; Authentication-Results: mx.google.com; dkim=pass header.i=@happypeps.co header.s=brevo2 header.b=Que7xnW0; dkim=pass header.i=@mailin.fr header.s=mail header.b=umrYJm3E; spf=pass (google.com: domain of bounces-m10df-info=happypeps.co@ht.d.sender-sib.com designates 77.32.148.46 as permitted sender) smtp.mailfrom="bounces-m10df-info=happypeps.co@ht.d.sender-sib.com"; dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=happypeps.co DKIM-Signature: a=rsa-sha256; bh=PoOQLY37ogW+D6I/xDjdxwlikPDxaBObL3v/xelGIQk=; c=relaxed/relaxed; d=happypeps.co; h=to:cc:from:reply-to:subject:date:mime-version:content-type:list-id:list-unsubscribe:x-csa-complaints:list-unsubscribe-post:message-id:sender:x-sib-id:x-mailin-client:x-mailin-campaign:feedback-id:bimi-selector; q=dns/txt; s=brevo2; t=1778713555; v=1; b=Que7xnW0GWZlWI9Q+j934LYZwAKRIu8IUJwMsltDWmacMMuIhr65JAfyQtF0lM3sryFk223F dZErPiKpVjxL1Mhdi3G7ipj9pwyFmTFujMPSNN/D7d/tt0sAb87gxVy2Pmj6y/oOqXE/9zDXhhH /3TDOY4Cjld5+494hb+z1uIdkSdu1CT6kwwk1rr4fRdEGEWSUKUUzxo0Mpvr3hF4v8yYJPRP9vs ckvnhO2Hi3vP874xB+I5jv570kWZyQY5ZD1LPaWmlcqRCCZWiVcv291iGCBL10QSGrZ7osKFkaa 2zgqMtKOQqLHyn5IPidUkqSZuVBL8KRndKskqSFe0G7Rw== DKIM-Signature: a=rsa-sha256; bh=PoOQLY37ogW+D6I/xDjdxwlikPDxaBObL3v/xelGIQk=; c=relaxed/relaxed; d=mailin.fr; h=to:cc:from:reply-to:subject:date:mime-version:content-type:list-id:list-unsubscribe:x-csa-complaints:list-unsubscribe-post:message-id:sender:x-sib-id:x-mailin-client:x-mailin-campaign:feedback-id:bimi-selector; q=dns/txt; s=mail; t=1778713555; v=1; b=umrYJm3Eb05rMw2cGKO7CcckbL3MJMzLiM4kMCfawYqkTTCScDuvPkR8csvh537hDRTlzAHU YFkjlioYpa8RzPQWAVCXf8x4O2ZtEVIkGMh1Jj1P+RdaBZEzI7N1AoxgTTuEWraZdmtBV4LWJiG 8W8WInuwQXTMQNXzx1yB3Tko= To: Subject: =?utf-8?q?=F0=9F=A7=AA_Peptide_Research_Roundup:_What=E2=80=99s_Trending_?= =?utf-8?q?in_2026?= Content-Type: multipart/alternative; boundary="-------?=_82412-4670577132896" Date: Wed, 13 May 2026 23:05:55 +0000 Feedback-ID: 77.32.148.46:10483343_91:10483343:Sendinblue From: happy peps List-Id: MTA0ODMzNDMtNzU4MS0y List-Unsubscribe: , List-Unsubscribe-Post: List-Unsubscribe=One-Click MIME-Version: 1.0 Message-Id: <202613052305.4acnyic841hrj@ht.d.sender-sib.com> Reply-To: X-Csa-Complaints: csa-complaints@eco.de X-Mailer: Sendinblue X-Mailin-Campaign: 91 X-Mailin-Client: 10483343 X-sib-id: VKLWRg3ArND4be5q2KXcaSwAYtlDdWYoapreNMLEzaO7bEP2kej91yz3TWZU-8SH5VAqUpDHs5WxWkwC3WZgwbq50OZgruA3H-a8RUlxpv0B_1YFzjiAz3nvhz2JJTXAt3XjlwDL6D8RrosE2PAUWRBoB5occtj5zYW0bgjblnAsX-pB8im3CqwlzOaEvMFuzL-M16PLi8E1Zb6e9SWzOTzVJqowrKK-cUsxIIiPKPhw ---------?=_82412-4670577132896 Content-Transfer-Encoding: quoted-printable Content-Type: text/plain; charset=UTF-8 [ SHOP NOW](#top) Hello Researchers, Peptide science is moving FAST in 2026, and we wanted to share a quick roun= dup of some of the biggest trends and breakthroughs currently making waves = in the research community. =F0=9F=A7=AC **1. Oral Peptides Are Advancing** Researchers are making major progress with oral peptide delivery systems de= signed to improve absorption and stability. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsEag0y0TMTOLkXHfeGNP= d/13KIGW61XF00](https://peptidestaff.com/news/oral-peptide-delivery-breakth= roughs-2026/) =E2=9A=96=EF=B8=8F **2. Next-Generation Metabolic Research Peptides** New multi-agonist peptides are becoming some of the most discussed compound= s in metabolic research. Trending names include: =E2=80=A2 Retatrutide =E2=80=A2 Amycretin =E2=80=A2 VK2735 Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsF30jAQriZJW0b73TF77= h/tWJveq3PdQz_](https://www.investors.com/news/technology/eli-lilly-weight-= loss-drug-retatrutide-black-market/) =F0=9F=A7=A0 **3. Longevity & Mitochondrial Research** Interest continues growing around peptides connected to recovery, cellular = signaling, and healthy aging research. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsFVLRMrG4fEgGewRIDqp= l/IJr6CgEpFHeI](https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsFxg9= ZHeQl9qWilp7CaXp/Dnfax0TSRGdA) =F0=9F=A4=96 **4. AI-Designed Peptides** Artificial intelligence is now helping researchers predict peptide interact= ions and develop new peptide structures faster than ever before. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsGQ0rli2mr50mmbCwBKF= t/QJzlEClrm_j9](https://arxiv.org/abs/2604.18467) =F0=9F=A7=AA **5. Peptide Stability Breakthroughs** Scientists recently discovered new enzyme technologies that may improve fut= ure peptide stability and delivery systems. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsGsLZy8R8x0B2qQalA3x= x/5_Mn_wRB8l4X](https://nypost.com/2026/05/02/us-news/scientists-discover-e= nzyme-that-could-supercharge-ozempic-like-weight-loss-drugs/) =F0=9F=8F=9B=EF=B8=8F **6. Regulatory Discussions Continue** Research peptide regulations and compounding discussions remain one of the = hottest topics in the industry this year. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsHKgIAYpV2vLIuFya8ng= 1/Jbln-GBNEIA1](https://www.allure.com/story/fda-peptide-ban-reversal) =F0=9F=93=88 **7. The Peptide Industry Keeps Growing** The peptide market continues expanding rapidly as interest in metabolic, lo= ngevity, and recovery research grows worldwide. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsHn10MzDr8qVYy5MP7XO= 5/LefqROF3mSLG](https://www.axios.com/2026/04/23/rfk-peptide-push-glp1-well= ness-boom) **Thank you for being part of the research community with us.** **=E2=80=94 HappyPeps [https://happypeps.co](https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/7nVU1aA= 2nfsZpYhztZtx9hNQNzY4lxB/oC7tP0wGTUHy)** **For Research Use Only. Not for Human Consumption.** ---------?=_82412-4670577132896 Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset=UTF-8 =F0=9F=A7=AA Peptide Research= Roundup: What=E2=80=99s Trending in 2026
AI-designed peptides, oral delivery research, GLP advancements & th= e latest trends shaping peptide science.‌   ­‌   &s= hy;‌   ­‌   ­‌   ­‌   &= shy;‌   ­‌   ­‌   ­‌   = ­‌   ­‌   ­‌   ­‌  = ­‌   ­‌   ­‌   ­‌  = ; ­‌   ­‌   ­‌   ­‌ &nbs= p; ­‌   ­‌   ­‌   ­‌ &nb= sp; ­‌   ­‌   ­‌   ­‌ &n= bsp; ­‌   ­‌   ­‌   ­‌ &= nbsp; ­‌   ­‌   ­‌   ­‌ =   ­‌   ­‌   ­‌   ­‌=   ­‌   ­‌   ­‌   ­&zwnj= ;   ­‌   ­‌   ­‌   ­&zwn= j;   ­‌   ­‌   ­‌   ­&zw= nj;   ­‌   ­‌   ­‌   ­&z= wnj;   ­‌   ­‌   ­‌   ­&= zwnj;   ­‌   ­‌   ­‌   ­= ‌   ­‌   ­‌   ­‌   ­= ;‌   ­‌   ­‌   ­‌   &sh= y;‌   ­‌   ­‌   ­‌   &s= hy;‌   ­‌   ­‌   ­‌   &= shy;‌   ­‌   ­‌   ­‌   = ­‌   ­‌   ­‌   ­‌  = ­‌   ­‌   ­‌   ­‌  = ; ­‌   ­‌   ­‌   ­‌ &nbs= p; ­‌   ­‌   ­‌   ­‌ &nb= sp; ­‌   ­‌   ­‌   ­‌ &n= bsp; ­‌   ­‌   ­‌   ­‌ &= nbsp; ­‌   ­‌   ­‌   ­‌ =   ­‌   ­‌   ­‌   ­‌=   ­‌   ­‌   ­‌   ­&zwnj= ;   ­‌   ­‌   ­‌   ­&zwn= j;   ­‌   ­‌   ­‌   ­&zw= nj;   ­‌   ­‌   ­‌   ­&z= wnj;   ­‌   ­‌   ­‌   ­&= zwnj;   ­‌   ­‌   ­‌   ­= ‌   ­‌   ­‌   ­‌   ­= ;‌   ­‌   ­‌   ­‌   &sh= y;‌   ­‌   ­‌   ­‌   &s= hy;‌   ­‌   ­‌   ­‌   &= shy;‌   ­‌   ­‌   ­‌   = ­‌   ­‌   ­‌   ­‌  = ­‌   ­‌   ­‌   ­‌  = ; ­‌   ­‌   ­‌   ­‌ &nbs= p; ­‌   ­‌   ­‌   ­‌ &nb= sp; ­‌   ­‌   ­‌   ­‌ &n= bsp; ­‌   ­‌   ­‌   ­‌ &= nbsp; ­‌   ­‌   ­‌   ­‌ =   ­‌   ­‌   ­‌   ­‌=   ­‌   ­‌   ­‌   ­&zwnj= ;   ­‌   ­‌   ­‌   ­&zwn= j;   ­
=
<= /tr>
<= td class=3D"r6-c" align=3D"center" style=3D"padding-bottom: 15px; padding-t= op: 15px; valign: top;"> 3D"www.happy= =
3D"www.happypeps.co"
SHOP NOW
=C2=AD
=C2=AD =C2=AD
=C2=AD


Hello Researchers,

Peptide science is moving FAST in 2026, and= we wanted to share a quick roundup of some of the biggest trends and break= throughs currently making waves in the research community.


=F0=9F=A7=AC 1. Oral Peptides Are Advancing=
Researchers are making major progress with oral peptide delivery system= s designed to improve absorption and stability.

Read more:
h= ttps://peptidestaff.com/news/oral-peptide-delivery-breakthroughs-2026/<= /p>


=E2=9A=96=EF=B8=8F 2. Next-Generation Metab= olic Research Peptides
New multi-agonist peptides are becoming = some of the most discussed compounds in metabolic research.

Trending names include:
=E2=80=A2 Retatr= utide
=E2=80=A2 Amycretin
=E2=80=A2 VK2735

Read more:
= https://www.investors.com/news/technology/eli-lilly-weight-loss-drug-retatr= utide-black-market/


=

=F0=9F=A7=A0 3. Lon= gevity & Mitochondrial Research
Interest continues growing = around peptides connected to recovery, cellular signaling, and healthy agin= g research.

Read more:
https://finance.yahoo.com/sectors/hea= lthcare/articles/formblends-publishes-2026-state-peptides-112500373.html


<= p style=3D"margin: 0; text-align: center;">=F0=9F=A4=96 4. AI-Desig= ned Peptides
Artificial intelligence is now helping researchers= predict peptide interactions and develop new peptide structures faster tha= n ever before.

Read more:https://arxiv.org/abs/2604.18467


=F0=9F=A7=AA 5. Peptide Stability Breakt= hroughs
Scientists recently discovered new enzyme technologies = that may improve future peptide stability and delivery systems.

Read more:
https://nypost.com/2026/05/02/us-news/scientists-discover-en= zyme-that-could-supercharge-ozempic-like-weight-loss-drugs/


=F0=9F=8F=9B=EF=B8=8F 6. Regulatory Discussions Contin= ue
Research peptide regulations and compounding discussions rem= ain one of the hottest topics in the industry this year.

Read more:
https://www.allure.com/story/fda-peptide-ban-reversal


=F0=9F=93=88 7. The Peptide Industry Keeps Growing<= /strong>
The peptide market continues expanding rapidly as interest in m= etabolic, longevity, and recovery research grows worldwide.

Read more:
https://www.axios.com/2026/04/23/rfk-peptide-push-glp1-wellness-= boom


Thank you for being part of the re= search community with us.

=E2=80=94 HappyPeps
https://happypeps.co

For Research Use Only. Not for Human Consumption.

 =C2=AD
=C2= =AD =C2=AD =C2=AD
If you wish to unsubscribe from our newsletter, click= here=
---------?=_82412-4670577132896--